Peter Ping Lin
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 23
- Cancer, Hypoxia, and Metabolism 5
- Oncology top 5%
- Cancer Cells and Metastasis 30
- Lung Cancer Research Studies 10
- Immunology top 5%
- Immunology and Allergy top 5%
- Cell Biology top 5%
- Cellular transport and secretion 8
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Cancer Research and Treatments 5
-
- Glycosylation and Glycoproteins Research 4
- Co-authors
- Marilyn G. FarquharJ HakimiDaisy Dandan WangMaurice K. GatelyUeli GublerChang SuKurt HollfelderA S Stern
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- United StatesChinaGermany
In The Last Decade
Peter Ping Lin
62 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 638
- Oncology 950
- Immunology 608
- Immunology and Allergy 130
- Cell Biology 258
Countries citing papers authored by Peter Ping Lin
This map shows the geographic impact of Peter Ping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ping Lin more than expected).
Fields of papers citing papers by Peter Ping Lin
This network shows the impact of papers produced by Peter Ping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ping Lin. The network helps show where Peter Ping Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Ping Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 0 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 21 | |
| 14 | 2019 | 34 | |
| 15 | 2018 | 46 | |
| 16 | 2016 | 24 | |
| 17 | 2013 | 31 | |
| 18 | 2009 | 81 | |
| 19 | 2006 | 34 | |
| 20 | 2002 | 19 |
About Peter Ping Lin
Peter Ping Lin is a scholar working on Cancer Research, Oncology and Structural Biology, having authored 69 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (30 papers), Cancer Genomics and Diagnostics (23 papers), Lung Cancer Research Studies (10 papers), Cellular transport and secretion (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer Research and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Cancer Research (638 citations), Oncology (950 citations) and Immunology (608 citations). Peter Ping Lin has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Marilyn G. Farquhar, J Hakimi, Daisy Dandan Wang, Maurice K. Gately, Ueli Gubler, Chang Su, Kurt Hollfelder, A S Stern, Y C Pan and Robert Hofmeister. Their work appears in journals such as Cancer Letters, Oncotarget, Journal of Biological Chemistry, BMC Cancer and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.